Neoadjuvant chemotherapy or chemoradiotherapy in head and neck cancer

Indian Journal of Cancer

Volumn 45, Issue 3, 2008, Pages 83-89

  Jain, Preetesh ^a   Kumar, Prabhash ^a   Pai, Vasanth Raghuvir ^a   Parikh, Purvish Mahendra ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Chemo radiation; Head and neck cancers; Induction chemotherapy

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CLINICAL TRIAL; HEAD AND NECK TUMOR; HUMAN; MULTIMODALITY CANCER THERAPY; REVIEW;

CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT;

EID: 57449116785     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.44061     Document Type: Review

References (19)

1. Garden AS, Asper JA, Morrison WH, et al. Is concurrent chemo radiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? Cancer 2004;100:1171-8.
2. Pignon JP, Bourhis J, Domenge C; Design LMACH-NC Collaborative Group. Chemotherapy added to loco regional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data, Meta-analysis of chemotherapy on head and neck cancer. Lancet 2000;355:949-55.
3. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, et al. Hyper fractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338:1798-804.
4. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999;91:2081-6.
5. Bourhis J, Amand C, Pignon J P. Update of MACH-NC (Meta-Analysis of Chemotherapy In Head and Neck Cancer) database focused on concomitant chemo radiotherapy. Proc Am Soc Clin Oncol 2004;22:14s.
6. Browman GP, Hodson Dl, Mackenzie RJ, Bestic N, Zuraw L; Cancer Care Ontario Practice Guideline Initiative Head and Neck Cancer Disease Site Group. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis. Head Neck 2001;23:579-89.
7. Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemo radiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21:92-8.
8. Olmi P, Crispino S, Fallai C, Torri V, Rossi F, Bolner A, et al. Locoregionally advanced carcinoma of the oropharynx: Conventional radiotherapy vs. accelerated hyper fractionated radiotherapy vs. concomitant radiotherapy and chemotherapy: A multicenter randomized trial. Int J Radiat Oncol Biol Phys 2003;55:78-92.
9. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567-78.
10. Bonner JA, Giralt J, Harari PM. Cetuximab prolongs survival in patients with loco regionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation therapy with or without cetuximab [abstract]. J Clin Oncol 2004;22:14s.
11. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945-52,72.
12. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-44.
13. Vermorken JB, Remenar E, Van Herpen C. Standard cisplatin/ infusional 5-fluorouracil (PF) vs. docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN): A phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971). Proc Am Soc Clin Oncol (Abstract 5508).
14. Hitt R, Lopez-Pousa A, Martinez-Trufero J, Escrig V, Carles J, Rizo A, et al. Phase III study comparing cisplatin plus fluorouracil to pacli-taxel, cisplatin, and fluorouracil induction chemotherapy followed by chemo radiotherapy in locally advanced head and neck cancer. J Clin Oncol 2005;23:8636-45.
15. Vermorken JB, Remenar E, Van Herpen C, GorliaT, Mesia R, Degardin M, et al. Cisplatin, fluorouracil and docetaxel in unresectable head and neck cancer. N Engl J Med 2007;357:1695-704.
16. Calais G, Pointreau Y, Alfonsi M. Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluoracil (F) with or without docetaxel (T) for organ preservation in hypo pharynx and larynx cancer. Preliminary results of GORTEC 2000-01. Proc Am Soc Clin Oncol 2006;24:281s.
17. Posner MR, Colevas AD, Tishler RB. The role of induction chemo-therapy in the curative treatment of squamous cell cancer of the head and neck. Semin Oncol 2000;27:13-24.
18. Hitt R, Lopez-Pousa A, Martinez-Trufero J, Escrig V, Carles J, Rizo A, et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemo radiotherapy In locally advanced head and neck cancer. J Clin Oncol 2005;23:8636-45.
19. Posner MR, Hershock DM, Blajman CR. Cisplatin, fluoracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705-15.